In conclusion, changing the membrane free cholesterol content alters the function and localization of both NTCP and OCT1, suggesting that individuals with liver conditions like NAFLD and NASH have impaired transporter capacities. The gene discussed is SLC10A1; the disease is metabolic dysfunction-associated steatohepatitis.